About Biofourmis
Biofourmis is a Healthcare company based in Boston (United States) founded in 2015 by Maulik Majmudar and Kuldeep Singh Rajput. It operates as a cloud-based patient monitoring solutions for healthcare are offered. It operates in the Healthcare and Technology sectors. Biofourmis has raised $465 million across 6 funding rounds from investors including Aviva, CVS Health and Fangzhou Jianke. The company has 106 employees. Biofourmis has completed 2 acquisitions, including Biovotion and Gaido Health. Biofourmis was last valued at $1.3 billion in July 2022. Its chief executive is Kuldeep Singh Rajput. Its Indian entity Biofourmis India Private Limited reported revenue of ₹69.70 Cr. Biofourmis offers products and services including Biofourmis Platform, Hospital at Home, and Drug Development Tools. Its focus areas include HealthTech, Healthcare IT, Horizontal and Suite Solutions. Its competitors include Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Biofourmis was founded in 2015 in Boston, United States, within the healthcare sector. Cloud-based suite solutions are provided for virtual care and patient monitoring. The Biovitals product is utilized for tracking patient engagement, communication, and vital signs. Clinical workflows and electronic health records are integrated to support care coordination across organizations. Operations focus on remote monitoring and data-driven healthcare delivery.
- Headquarters Boston, United States
- Employees 106
- Founders Maulik Majmudar, Kuldeep Singh Rajput
- Stage Unicorn
- SectorsHealthcareTechnology
- Email••••••••
- Website biofourmis.com
- Social LinkedIn X
- Legal Name Biofourmis India Private Limited
- Date of Incorporation 08 Nov, 2017
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of Biofourmis
Biofourmis operates through Biofourmis India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biofourmis India Private Limited CIN U72100KA2017PTC156202 | Active | 08 Nov 2017 | Bangalore, Karnataka | ₹69.7 Cr | 73 | 2 | View details |
Products & Services of Biofourmis
Biofourmis offers a comprehensive portfolio of products and services, including Biofourmis Platform, Hospital at Home, and Drug Development Tools.
Platform for remote monitoring and care delivery services.
Solution enabling home-based hospital services and patient management.
Tools for managing drug life cycles and clinical trials.
Apps and channels of Biofourmis
Biofourmis publishes 1 mobile app with over 1K+ downloads.
Funding Insights of Biofourmis
Biofourmis has successfully raised a total of $465M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $465M
- Total Rounds 6
- Last Round Series D — $20M
- First Round $1M
(Aug 2017)
- Investors Count 17
All 6 funding rounds of Biofourmis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $20M | Series D | – | Intel Capital | – |
| Apr 2022 | $300M | Series D | $1.3B | General Atlantic | |
| Sep 2020 | $100M | Series C | $700M | SoftBank Vision Fund | |
| May 2019 | $35M | Series B | – | – | |
| Dec 2017 | $5M | Series A | – | Aviva, Openspace Ventures | – |
| Aug 2017 | $1M | Seed | – | SpesNet, Eden Strategy Institute | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2022 | $1.3B | •••••••• |
| Sep 2020 | $700M | •••••••• |
Full valuation and stage history of Biofourmis
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1.3B (Jul 2022). 17 investors in total: 16 institutional and 1 angel.
Investors in Biofourmis
Biofourmis has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Aviva, CVS Health and Fangzhou Jianke.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in technology startups focusing on compute, AI, and related innovations. | – | intelcapital.com | - | |
Private equity fund focused on global markets | 1980 | generalatlantic.com | New York, United States | |
Early-stage technology startups are invested in by Openspace Ventures. | – | openspace.vc | Singapore, Singapore | |
Government-backed investments are directed toward healthcare, fintech, and various sectors. | – | edbi.com | Singapore, Singapore | |
Venture capital investments in technology and startups. | 2016 | visionfund.com | London, United Kingdom | |
Corporate-backed venture capital fund | – | massmutualventures.com | Boston, United States | |
Venture capital firm investing in startups and providing support programs. | 2000 | peakxv.com | Bengaluru, India | |
Early-stage deep tech startups are funded by SGInnovate in Singapore. | – | sginnovate.com | Singapore, Singapore | |
Corporate venture capital investments in innovative technologies are facilitated. | – | pmequitypartner.com | Lausanne, Switzerland | |
Early-stage venture capital investments in deep tech are provided. | – | 2050cap.com | London, United Kingdom |
Investor details for Biofourmis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biofourmis India Private Limited (Biofourmis)
Biofourmis India Private Limited is the primary company behind Biofourmis. The board of Biofourmis India Private Limited currently have 2 directors; the longest-serving is Roopa Ramalingamurthy, appointed in 2024. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Roopa Ramalingamurthy DIN 07611510 | Director | 12 Jun 2024 | 2 yrs 4 mo | Biofourmis India Private Limited |
| Raghu Charan Mallena DIN 11121585 | Additional Director | 26 May 2025 | 1 yr 4 mo | Biofourmis India Private Limited |
People of Biofourmis
72 people are tracked at Biofourmis (28 in leadership, 3 in board & advisors, 41 in team); the tracked headcount is 106.
| Name | Role | Group |
|---|---|---|
Maulik Majmudar | Co-Founder & Chief Medical Officer | Leadership |
Kuldeep Singh Rajput | Co-Founder & CEO | Leadership |
Matt Lisowski | Chief Product Officer | Leadership |
| Global Head, Engineering | Leadership | |
Krishna Kamath | Vice President Delivery | Leadership |
Shruthi Krishnamurthy | Delivery Director | Leadership |
Will Gray | COO | Leadership |
Felix Pomerantz | CFO | Leadership |
Ramesh Kedlaya | Senior Director Of Engineering | Leadership |
| HR Director | Leadership | |
Andy Chung | Senior Vice President Of Customer Success | Leadership |
Avani N. | Director, Data Engineering | Leadership |
Andrew D. Zucker | Vice President Global Human Resources | Leadership |
Arvind Prabhu | Senior Director - Finance | Leadership |
Beth Leonard | Senior Director, Customer Success | Leadership |
Danny Plooster | Director, Customer Success | Leadership |
David Koretz | CEO | Leadership |
Ashley Sosnoski | Associate Vice President, Global Privacy Compliance Officer | Leadership |
Seth Kuzdzal | Senior Vice President Quality Assurance And Regulatory Affairs Biofourmis | Leadership |
Michael Tam | Associate Director, Customer Support | Leadership |
52 more people are available in the full profile.
Complete people profiles for Biofourmis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biofourmis
Figures of Biofourmis India Private Limited, the primary company behind Biofourmis, for FY 2025. Revenue was ₹69.70 Cr (-32% year on year). Net profit was ₹6.14 Cr (9% margin). EBITDA was ₹11.41 Cr (16% margin). Revenue has grown at a compounded annual rate of +15% over three years and +73% over five years.
- ₹69.70 CrRevenue · FY 2025 · -32% YoY
- ₹6.14 CrNet profit · 9% margin
- ₹11.41 CrEBITDA · 16% margin
- ₹9 LakhPaid-up capital
- 73Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +73%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biofourmis India Private Limited are on its company page.
Detailed financial statements for Biofourmis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biofourmis
Biofourmis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Biovotion and Gaido Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
AI-enabled early detection services for healthcare are provided. | gaidohealth.com | Manhattan Beach, United States | 2018 | Apr 2020 | •••• | |
Patient health vitals are monitored remotely via Biovotion's wearable devices. | biovotion.com | Zurich, Switzerland | 2011 | Nov 2019 | •••• |
Complete acquisition details for Biofourmis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biofourmis
7 dated milestones of Biofourmis across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Biofourmis is founded.
- Funding First funding round of $1.0M.
- Acquisition Acquires Biovotion.
- Acquisition Acquires Gaido Health.
- Milestone Reaches Minicorn status.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series D, of $20.0M.
Competitors of Biofourmis
Biofourmis has 9 listed competitors in our database, 6 of them funded. They include Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| healthcatalyst.com | 2008 | Salt Lake, United States | $392M | 1,183 | Cloud-based data analytics are provided for healthcare organizations. | |
| citiustech.com | 2005 | Princeton, United States | $1.13B | 5,442 | Provider of AI solutions for clinical, operational, and business outcomes | |
| azaleahealth.com | 2008 | Atlanta, United States | $12.31M | 212 | EHR Platform with integrated Telehealth, Mobile health and RCM solutions for healthcare providers | |
| cgm.com | 1987 | Koblenz, Germany | – | 7,814 | Suite of practice management, reimbursement, laboratory and analytics solutions to healthcare providers | |
| ikshealth.com | 2006 | Navi Mumbai, India | $9.35M | 7,633 | Provider of healthcare technology and services for revenue cycle management and clinical support | |
| drfirst.com | 2000 | Rockville, United States | $85.8M | 401 | E-prescription and secure messaging solutions are offered to healthcare providers. | |
| innovaccer.com | 2014 | San Francisco, United States | $675M | 1,125 | Provider of an AI-powered cloud platform for healthcare performance improvement | |
| nextgen.com | 1974 | Horsham, United States | – | 1,974 | Cloud-based administration solutions for healthcare providers are delivered. | |
| epic.com | 1979 | Madison, United States | – | 10,964 | Provider of suite software solutions for healthcare organizations |
Detailed competitors of Biofourmis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biofourmis
The website of Biofourmis (biofourmis.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▼ 44.8% vs previous month
Websites whose visitors overlap most with Biofourmis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mobihealthnews.com | 100% | 133.6K | #351,855 | View details | |
| hitconsultant.net | 80% | 680.7K | #747,525 | View details | |
| statnews.com | 80% | – | #28,251 | View details | |
| hcinnovationgroup.com | 60% | – | #1,222,007 | View details |
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Biofourmis (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biofourmis
Complete news archive for Biofourmis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biofourmis
Biofourmis was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Biofourmis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Kuldeep Singh Rajput is the current CEO of Biofourmis. They have also founded this company.
Biofourmis is a funded company, having raised a total of $465M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Aug 2017.
Biofourmis has 106 employees.
The primary company behind Biofourmis, Biofourmis India Private Limited, reported revenue of ₹69.70 Cr for FY 2025, down 32% year on year.
Biofourmis was founded in 2015 in Boston, United States, within the healthcare sector. Cloud-based suite solutions are provided for virtual care and patient monitoring. The Biovitals product is utilized for tracking patient engagement, communication, and vital signs. Clinical workflows and electronic health records are integrated to support care coordination across organizations. Operations focus on remote monitoring and data-driven healthcare delivery.
Biofourmis's top competitors include IKS Health, Innovaccer and CompuGroup Medical.
Biofourmis offers Biofourmis Platform, Hospital at Home, and Drug Development Tools.
Biofourmis has made 2 acquisitions, including Biovotion, and Gaido Health.
Biofourmis has 17 investors. Key investors include Aviva, CVS Health, Fangzhou Jianke, General Atlantic, and Peak XV Partners.
The valuation of Biofourmis is $1.3B as of Jul 2022.